SCHEMBL7041587

SCHEMBL7041587

COc1ccc(CC2CCCCC2=O)cc1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.70
CA1 P00915 7/20 0.70
CA4 P22748 3/20 0.70
CA6 P23280 3/20 0.70
KMT2A Q03164 3/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.49
CYP3A4 P08684 1/20 0.49
PDE4B Q07343 1/20 0.48
CA9 Q16790 4/20 0.48
CA12 O43570 2/20 0.48
MAPK1 P28482 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
PTGS1 P23219 2/20 0.46
PTGS2 P35354 2/20 0.46
OPRK1 P41145 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7489248 0.89 CA1 (0.67) CA2CA1CA4CA6KMT2A
SCHEMBL28060653 0.87 CA1 (0.65) CA2CA1CA4CA6KMT2A
SCHEMBL11792546 0.87 CA2 (0.53) CA2CA1CA4CA6KMT2A
SCHEMBL31497113 0.86 CA1 (0.53) CA2CA1CA4CA6KMT2A
SCHEMBL31497114 0.86 CA1 (0.53) CA2CA1CA4CA6KMT2A
SCHEMBL13074083 0.85 CA2 (0.51) CA2CA1CA4CA6KMT2A
SCHEMBL13074243 0.85 CA2 (0.51) CA2CA1CA4CA6KMT2A
SCHEMBL19050091 0.85 CA2 (0.51) CA2CA1CA4CA6KMT2A
SCHEMBL8065454 0.81 CA1 (0.57) CA2CA1CA4CA6KMT2A
SCHEMBL3144588 0.81 CA1 (0.57) CA2CA1CA4CA6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017107789-A1 COMPOUND HAVING CHIRAL SPIROBIINDANE SKELETON AND PREPARATION METHOD THEREFOR 浙江九洲药业股份有限公司 2017-06-29 WO disclosed
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed